Neuro-ophthalmologic alterations in patients with movement disorders

Uncommon Causes of Movement Disorders

Volumn , Issue , 2011, Pages 306-315

  Jan, Kassubek ^a   Pinkhardt, Elmar H ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902187090     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511977749.030     Document Type: Chapter

References (91)

1. Hamilton SR. Neuro-ophthalmology of movement disorders. Curr Opin Ophthalmol2000; 11(6): 403–7
2. Wong A. Eye Movement Disorders. 14th ed. Oxford: Oxford University Press; 2008
3. Bronstein AM, Mossman S, Luxon LM. The neck-eye reflex in patients with reduced vestibular and optokinetic function. Brain1991; 114(Pt 1A): 1–11
4. Leigh RJ, Zee DS. The Neurology of Eye Movements. 4th ed. Oxford: Oxford University Press; 2006
5. Waterston JA, Barnes GR, Grealy MA, Collins S. Abnormalities of smooth eye and head movement control in Parkinson’s disease. Ann Neurol1996; 39(6): 749–60
6. Izawa Y, Suzuki H, Shinoda Y. Response properties of fixation neurons and their location in the frontal eye field in the monkey. J Neurophysiol2009; 102(4): 2410–22
7. McDowell JE, Dyckman KA, Austin BP, Clementz BA. Neurophysiology and neuroanatomy of reflexive and volitional saccades: evidence from studies of humans. Brain Cogn2008; 68(3): 255–70
8. Mikami A, Ito S, Kubota K. Visual response properties of dorsolateral prefrontal neurons during visual fixation task. J Neurophysiol1982; 47(4): 593–605
9. Muri RM, Nyffeler T. Neurophysiology and neuroanatomy of reflexive and volitional saccades as revealed by lesion studies with neurological patients and transcranial magnetic stimulation (TMS). Brain Cogn2008; 68(3): 284–92
10. Vidailhet M, Rivaud S, Gouider-Khouja N et al. Eye movements in parkinsonian syndromes. Ann Neurol1994; 35(4): 420–6
11. Cazzoli D, Muri RM, Hess CW, Nyffeler T. Horizontal and vertical dimensions of visual extinction: a theta burst stimulation study. Neuroscience2009; 164(4): 1609–14
12. Dieterich M, Muller-Schunk S, Stephan T, Bense S, Seelos K, Yousry TA. Functional magnetic resonance imaging activations of cortical eye fields during saccades, smooth pursuit, and optokinetic nystagmus. Ann N Y Acad Sci2009; 1164: 282–92
13. Poewe W. The natural history of Parkinson’s disease. J Neurol 2006; 253(Suppl 7): VII2–6
14. Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K. Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsidered. Mov Disord2006; 21(12): 2042–51
15. Braak H, Del Tredici K. Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurology2008; 70(20): 1916–25
16. Braak H, Muller CM, Rub U et al. Pathology associated with sporadic Parkinson’s disease – where does it end? J Neural Transm Suppl 2006; (70): 89–97
17. Lang AE, Obeso JA. Challenges in Parkinson’s disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol2004; 3(5): 309–16
18. Salman MS, Sharpe JA, Lillakas L, Steinbach MJ. Square wave jerks in children and adolescents. Pediatr Neurol2008; 38(1): 16–19
19. Serra A, Dell’Osso LF, Jacobs JB, Burnstine RA. Combined gaze-angle and vergence variation in infantile nystagmus: two therapies that improve the highvisual- acuity field and methods to measure it. Invest Ophthalmol Vis Sci2006; 47(6): 2451–60
20. Sprenger A, Neppert B, Koster S et al. Long-term eye movement recordings with a scleral search coil-eyelid protection device allows new applications. J Neurosci Methods2008; 170(2): 305–9
21. van der Geest JN, Frens MA. Recording eye movements with video-oculography and scleral search coils: a direct comparison of two methods. J Neurosci Methods2002; 114(2): 185–95
22. Eggert T. Eye movement recordings: methods. Dev Ophthalmol2007; 40: 15–34
23. Houben MM, Goumans J, van der Steen J. Recording three-dimensional eye movements: scleral search coils versus video oculography. Invest Ophthalmol Vis Sci2006; 47(1): 179–87
24. Kimmig H, Greenlee MW, Gondan M, Schira M, Kassubek J, Mergner T. Relationship between saccadic eye movements and cortical activity as measured by fMRI: quantitative and qualitative aspects. Exp Brain Res2001; 141(2): 184–94
25. Kimmig H, Ohlendorf S, Speck O et al. fMRI evidence for sensorimotor transformations in human cortex duringsmooth pursuit eye movements. Neuropsychologia2008; 46(8): 2203–13
26. Amador SC, Hood AJ, Schiess MC, Izor R, Sereno AB. Dissociating cognitive deficits involved in voluntary eye movement dysfunctions in Parkinson’s disease patients. Neuropsychologia2006; 44(8): 1475–82
27. Armstrong IT, Chan F, Riopelle RJ, Munoz DP. Control of saccades in Parkinson’s disease. Brain Cogn 2002;49(2): 198–201
28. Briand KA, Strallow D, Hening W, Poizner H, Sereno AB. Control of voluntary and reflexive saccades in Parkinson’s disease. Exp Brain Res1999; 129(1): 38–48
29. Rieger JW, Kim A, Argyelan M et al. Cortical functional anatomy of voluntary saccades in Parkinson disease. Clin EEG Neurosci2008; 39(4): 169–74
30. Chan F, Armstrong IT, Pari G, Riopelle RJ, Munoz DP. Deficits in saccadic eye-movement control in Parkinson’s disease. Neuropsychologia2005; 43(5): 784–96
31. van Stockum S, MacAskill M, Anderson T, Dalrymple- Alford J. Don’t look now or look away: two sources of saccadic disinhibition in Parkinson’s disease? Neuropsychologia2008; 46(13): 3108–15
32. Pierrot-Deseilligny C, Muri RM, Nyffeler T, Milea D. The role of the human dorsolateral prefrontal cortex in ocular motor behavior. Ann N Y Acad Sci2005; 1039: 239–51
33. Pinkhardt EH, Kassubek J, Sussmuth S, Ludolph AC, Becker W, Jurgens R. Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson’s disease. J Neurol2009; 256(9): 1438–46
34. Pierrot-Deseilligny C, Muri RM, Ploner CJ, Gaymard B, Demeret S, Rivaud-Pechoux S. Decisional role of the dorsolateral prefrontal cortex in ocular motor behaviour. Brain2003; 126(Pt 6): 1460–73
35. Rascol O, Clanet M, Montastruc JL et al. Abnormal ocular movements in Parkinson’s disease: evidence for involvement of dopaminergic systems. Brain1989; 112(Pt 5): 1193–214
36. Vermersch AI, Rivaud S, Vidailhet M et al. Sequences of memory-guided saccades in Parkinson’s disease. Ann Neurol1994; 35(4): 487–90
37. Crevits L, Versijpt J, Hanse M, De Ridder K. Antisaccadic effects of a dopamine agonist as add-on therapy in advanced Parkinson’s patients. Neuropsychobiology2000; 42(4): 202–6
38. Gibson JM, Kennard C. Quantitative study of “on-off” fluctuations in the ocular motor system in Parkinson’s disease. Adv Neurol1987; 45: 329–33
39. Hood AJ, Amador SC, Cain AE et al. Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson’s disease. J Neurol Neurosurg Psychiatry2007; 78(6): 565–70
40. Michell AW, Xu Z, Fritz D et al. Saccadic latency distributions in Parkinson’s disease and the effects of l-dopa. Exp Brain Res2006; 174(1): 7–18
41. Rivaud-Pechoux S, Vidailhet M, Gallouedec G, Litvan I, Gaymard B, Pierrot-Deseilligny C. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology2000; 54(5): 1029–32
42. Sauleau P, Pollak P, Krack P et al. Subthalamic stimulation improves orienting gaze movements in Parkinson’s disease. Clin Neurophysiol2008; 119(8): 1857–63
43. Hikosaka O. Role of basal ganglia in saccades. Rev Neurol (Paris)1989; 145(8–9): 580–6
44. Hikosaka O, Takikawa Y, Kawagoe R. Role of the basal ganglia in the control of purposive saccadic eye movements.Physiol Rev 2000; 80(3): 953–78
45. Temel Y, Visser-Vandewalle V, Carpenter RH. Saccadic latency during electrical stimulation of the human subthalamic nucleus. Curr Biol2008; 18(10): R412–4
46. Temel Y, Visser-Vandewalle V, Carpenter RH. Saccadometry: a novel clinical tool for quantification of the motor effects of subthalamic nucleus stimulation in Parkinson’s disease. Exp Neurol2009; 216(2): 481–9
47. Yoshida M, Sone M. Mechanism of neuronal degeneration of multiple system atrophy. Brain Nerve2009; 61(9): 1051–60
48. Pierrot-Deseilligny C, Muri RM, Ploner CJ, Gaymard B, Rivaud-Pechoux S. Cortical control of ocular saccades in humans: a model for motricity. Prog Brain Res2003; 142: 3–17
49. Anderson T, Luxon L, Quinn N, Daniel S, Marsden CD, Bronstein A. Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Mov Disord2008; 23(7): 977–84
50. Ludolph AC, Kassubek J, Landwehrmeyer BG et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol2009; 16(3): 297–309
51. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol1964; 10: 333–59
52. Williams DR, Lees AJ, Wherrett JR, Steele JC. J. Clifford Richardson and 50 years of progressive supranuclear palsy. Neurology2008; 70(7): 566–73
53. Pinkhardt EH, Jurgens R, Becker W, Valdarno F, Ludolph AC, Kassubek J. Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson’s syndrome, and idiopathic Parkinson’s disease. J Neurol2008; 255(12): 1916–25
54. Morris HR, Wood NW, Lees AJ. Progressive supranuclear palsy (Steele–Richardson–Olszewski disease). Postgrad Med J1999; 75(888): 579–84
55. Revesz T, Sangha H, Daniel SE. The nucleus raphe interpositus in the Steele-Richardson–Olszewski syndrome (progressive supranuclear palsy). Brain1996; 119(Pt 4): 1137–43
56. Suzuki Y, Buttner-Ennever JA, Straumann D, Hepp K, Hess BJ, Henn V. Deficits in torsional and vertical rapid eye movements and shift of Listing’s plane after uniand bilateral lesions of the rostral interstitial nucleus of the medial longitudinal fasciculus. Exp Brain Res1995; 106(2): 215–32
57. Williams DR, de Silva R, Paviour DC et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism. Brain2005; 128(Pt 6): 1247–58
58. Williams DR, Holton JL, Strand C et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson’s syndrome. Brain2007; 130(Pt 6): 1566–76
59. Boxer AL, Garbutt S, Rankin KP et al. Medial versus lateral frontal lobe contributions to voluntary saccade control as revealed by the study of patients with frontal lobe degeneration. J Neurosci2006; 26(23): 6354–63
60. Garbutt S, Matlin A, Hellmuth J et al. Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer’s disease. Brain2008; 131(Pt 5): 1268–81
61. Moon SY, Lee BH, Seo SW, Kang SJ, Na DL. Slow vertical saccades in the frontotemporal dementia with motor neuron disease. J Neurol2008; 255(9): 1337–43
62. Abel LA, Walterfang M, Fietz M, Bowman EA, Velakoulis D. Saccades in adult Niemann–Pick disease type C reflect frontal, brainstem, and biochemical deficits. Neurology2009; 72(12): 1083–6
63. Rottach KG, von Maydell RD, Das VE et al. Evidence for independent feedback control of horizontal and vertical saccades from Niemann–Pick type C disease. Vision Res1997; 37(24): 3627–38
64. Solomon D, Winkelman AC, Zee DS, Gray L, Buttner- Ennever J. Niemann–Pick type C disease in two affected sisters: ocular motor recordings and brain-stem neuropathology. Ann N Y Acad Sci 2005; 1039: 436–45
65. Walterfang M, Fietz M, Abel L, Bowman E, Mocellin R, Velakoulis D. Gender dimorphism in siblings with schizophrenia-like psychosis due to Niemann–Pick disease type C. J Inherit Metab Dis 2009 Jul 17. doi:10.1007/s10545-009-1173-1
66. Bithell A, Johnson R, Buckley NJ. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington’s disease. Biochem Soc Trans2009; 37(Pt 6): 1270–5
67. Tabrizi SJ, Langbehn DR, Leavitt BR et al. Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: cross- sectionalanalysis of baseline data. Lancet Neurol 2009; 8(9): 791–801
68. Kirkwood SC, Siemers E, Stout JC et al. Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Arch Neurol1999; 56(5): 563–8
69. Becker W, Jurgens R, Kassubek J, Ecker D, Kramer B, Landwehrmeyer B. Eye–head coordination in moderately affected Huntington’s disease patients: do head movements facilitate gaze shifts? Exp Brain Res 2009; 192(1): 97–112
70. Leigh RJ, Newman SA, Folstein SE, Lasker AG, Jensen BA. Abnormal ocular motor control in Huntington’s disease. Neurology1983; 33(10): 1268–75
71. Kloppel S, Draganski B, Golding CV et al. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington’s disease. Brain2008; 131(Pt 1): 196–204
72. Gradstein L, Danek A, Grafman J, Fitzgibbon EJ. Eye movements in chorea-acanthocytosis. Invest Ophthalmol Vis Sci2005; 46(6): 1979–87
73. Egan RA, Weleber RG, Hogarth P et al. Neuroophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden–Spatz syndrome). Am J Ophthalmol2005; 140(2): 267–74
74. Hayflick SJ. Unraveling the Hallervorden–Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name. Curr Opin Pediatr2003; 15(6): 572–7
75. Lennox G, Jones R. Gaze distractibility in Wilson’s disease. Ann Neurol1989; 25(4): 415–7
76. Lesniak M, Czlonkowska A, Seniow J. Abnormal antisaccades and smooth pursuit eye movements in patients with Wilson’s disease. Mov Disord2008; 23(14): 2067–73
77. Ingster-Moati I, Bui Quoc E, Pless M et al. Ocular motility and Wilson’s disease: a study on 34 patients. J Neurol Neurosurg Psychiatry2007; 78(11): 1199–201
78. Oder W, Prayer L, Grimm G et al. Wilson’s disease: evidence of subgroups derived from clinical findings and brain lesions. Neurology1993; 43(1): 120–4
79. Barthel H, Hermann W, Kluge R et al. Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease. AJNR Am J Neuroradiol2003; 24(2): 234–8
80. Kitzberger R, Madl C, Ferenci P. Wilson disease. Metab Brain Dis2005; 20(4): 295–302
81. Buttner N, Geschwind D, Jen JC, Perlman S, Pulst SM, Baloh RW. Oculomotor phenotypes in autosomal dominant ataxias. Arch Neurol1998; 55(10): 1353–7
82. Wadia N, Pang J, Desai J, Mankodi A, Desai M, Chamberlain S. A clinicogenetic analysis of six Indian spinocerebellar ataxia (SCA2) pedigrees. The significance of slow saccades in diagnosis. Brain1998; 121(Pt 12): 2341–55
83. Ohyagi Y, Yamada T, Okayama A et al. Vergence disorders in patients with spinocerebellar ataxia 3/Machado–Joseph disease: a synoptophore study. J Neurol Sci2000; 173(2): 120–3
84. Schols L, Amoiridis G, Buttner T, Przuntek H, Epplen JT, Riess O. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? Ann Neurol 1997; 42(6): 924–32
85. Mariotti C, Alpini D, Fancellu R et al. Spinocerebellar ataxia type 17 (SCA17): oculomotor phenotype and clinical characterization of 15 Italian patients. J Neurol2007; 254(11): 1538–46
86. Gilbert DL, Christian BT, Gelfand MJ, Shi B, Mantil J, Sallee FR. Altered mesolimbocortical and thalamic dopamine in Tourette syndrome. Neurology2006; 67(9): 1695–7
87. LeVasseur AL, Flanagan JR, Riopelle RJ, Munoz DP. Control of volitional and reflexive saccades in Tourette’s syndrome. Brain2001; 124(Pt 10): 2045–58
88. Munoz DP, Le Vasseur AL, Flanagan JR. Control of volitional and reflexive saccades in Tourette’s syndrome. Prog Brain Res2002; 140: 467–81
89. Nomura Y, Fukuda H, Terao Y, Hikosaka O, Segawa M. Abnormalities of voluntary saccades in Gilles de la Tourette’s syndrome: pathophysiological consideration. Brain Dev2003; 25(Suppl 1): S48–54
90. Thomalla G, Siebner HR, Jonas M et al. Structural changes in the somatosensory system correlate with tic severity in Gilles de la Tourette syndrome. Brain2009; 132(Pt 3): 765–77
91. Mueller SC, Jackson GM, Dhalla R, Datsopoulos S, Hollis CP. Enhanced cognitive control in young people with Tourette’s syndrome. Curr Biol2006; 16(6): 570–3